| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |